Prellis Biologics

Prellis Biologics is a biotechnology company that creates 3D printing filaments for the life sciences industry. The company was founded in 2013 by two Stanford engineers, John Hart and Stefan Savage. Prellis' mission is to "advance tissue engineering and regenerative medicine by providing researchers with novel 3D printing filaments that enable more accurate and reproducible tissue engineering constructs."